Business Standard

ERIS Lifesciences standalone net profit rises 8.99% in the September 2019 quarter

Image

Capital Market

Sales rise 13.22% to Rs 268.42 crore

Net profit of ERIS Lifesciences rose 8.99% to Rs 91.53 crore in the quarter ended September 2019 as against Rs 83.98 crore during the previous quarter ended September 2018. Sales rose 13.22% to Rs 268.42 crore in the quarter ended September 2019 as against Rs 237.07 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales268.42237.07 13 OPM %39.9440.95 -PBDT111.7097.07 15 PBT101.3289.99 13 NP91.5383.98 9

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 08 2019 | 11:22 AM IST

Explore News